Opening book details…
About this Medicine article
A Novel Multi-target Tyrosine Kinase Inhibitor Anlotinib Combined with Irinotecan Has In-vitro Anti-tumor Activity Against Human Small-cell Lung Cancer by Li, Hui; Liu, Yan; Liu, Xianhong; Zhao, Dandan; Liu, Jingjing; Cheng, Ying is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Li, Hui; Liu, Yan; Liu, Xianhong; Zhao, Dandan; Liu, Jingjing; Cheng, Ying
- Publisher
- Lippincott Williams and Wilkins; Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins; Lippincott Williams & Wilkins Ltd.; Ovid Technologies (Wolters Kluwer Health) (ISSN 0959-4973)
- Published
- 2020
- Field
- Medicine (Health Sciences)
More by Li, Hui; Liu, Yan; Liu, Xianhong; Zhao, Dandan; Liu, Jingjing; Cheng, Ying
Browse all works by Li, Hui; Liu, Yan; Liu, Xianhong; Zhao, Dandan; Liu, Jingjing; Cheng, Ying